12:22 PM EST - Trillium Therapeutics Inc. : Today announced that Paul Walker has been appointed to the Company’s Board of Directors, and Dr. Ali Behbahani has been appointed as a Board Observer, effective February 6. Trillium Therapeutics Inc.
shares T.TRIL are trading up 0.26 at $5.26.
